The MedTech Actuator™ does not take equity for participation in the program. The cost of the programme is S$7,000 per person.
A subsidised rate of S$5000 will be available for Singapore startups with at least 30% Singapore shareholding. Up to 2 representatives per startup is able to participate in the program at this subsidised rate.
For Singapore startups: All online seminars, plane tickets to, from and within Australia, lodging as well as food and transportation within the scheduled program in Australia.
For all other startups: All online seminars, lodging as well as food and transportation within the scheduled program in Australia. Flights and transportation from and to the airport are not included for non-Singaporean startups.
Our program is targeted towards MedTech, HealthTech, and BioTech startups ~TRL 4 and above. Our specialty is deep tech with robust IP and a regulated path to market. Slick apps and user interfaces are great, but what gets us excited are radical new technologies like bionics, diagnostics, implants, instrumentation, robotics, personal preventative medicine, telemedicine, AI and VR that will create a step-change in our healthcare systems and economies.
If you are unsure about eligibility or have any other questions about our program, you can speak to our Head of International Programmes before submitting an application.
Please submit your application through the Apply Now button on the webpage. Please also attach a pitch deck introducing your company, the needs that your innovation addresses, the technology behind the innovation, which stage of development is your product at and other relevant information that you deem fit.
If your application is shortlisted, you’ll hear from us via email. The most promising teams will be offered a place in the MedTech Actuator Global Navigator Program.
We look for passionate, well-rounded founder teams with strong skills in key areas such as technology, clinical, business and commercialisation that have a unique insight into their market and are high-integrity and inspiring leaders with a focus on execution.
Ideas matter but the execution makes the difference. That is why we like to see evidence of early traction or data points validating your core assumptions such as early proof of concept and safety data, a robust need validation, or expressions of interest from lead users or customers.
The MedTech Actuator Global Navigator program is a market-access program that facilitates a smooth and accelerated pathway for growing ventures to both gain a deep insight into the market and access critical stakeholders in the Australian ecosystem as they expand their international efforts and capture new market opportunities.
The MedTech Actuator Global Navigator requires full-time participation for both the virtual sessions held in Singapore time and the in-person visit to Melbourne.
The MedTech Actuator Global Navigator is a well-rounded program comprising many segments that come together to provide startups with a comprehensive suite of resources.
We ensure that you are prepared for the visit by providing localised knowledge and deep insights on the destination’s ecosystem with experts. With this insight and knowledge, you will then prepare a more focused pitch and expansion strategy.
At the destination ecosystem, you will meet ecosystem stakeholders to advise on how to break-down barriers to entry and explore strategic tactics to assist your business to flourish. You will also put your pitch training into practice with tailored investor lunches. On top of group meetings, we will also facilitate one-to-one meetings with stakeholders that are curated to your needs.
A mentor will also be assigned to you for weekly 1-hour mentoring sessions for a period of 2 months. Through this mentorship, you will gain insight to market hurdles with mitigation tips from someone who has experienced and succeeded in bringing their product to market.
There are no restrictions to where you are based, so long as you are able to attend the online sessions held in Singapore Time. You must also be able to attend the in-person Perth segment of the program.
For the first part of the application process, the MedTech Actuator team will be assessing applications internally. If asked to provide further information for due diligence, MedTech Actuator partners, including MinterEllison and FBRice, will provide services to assist the team.
Startups that get through to the next round will undergo deep due diligence and will be required to pitch – with Q&A – to our Innovation Assessment Board, made up of our global corporate partners, clinical partners, product development partners and legal partners.